{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:28Z","timestamp":1791357508789,"version":"4.3.1"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.37259","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T21:32:41Z","timestamp":1613424761000},"page":"e2037259","source":"Crossref","is-referenced-by-count":69,"title":["Projected Estimates of Opioid Mortality After Community-Level Interventions"],"prefix":"10.1001","volume":"4","author":[{"given":"Benjamin P.","family":"Linas","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"},{"name":"Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Savinkina","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. W. M. A.","family":"Madushani","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Wang","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Eftekhari Yazdi","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Grayken Center for Addiction at Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y.","family":"Walley","sequence":"additional","affiliation":[{"name":"Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Grayken Center for Addiction at Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake R.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"},{"name":"Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina A.","family":"Assoumou","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"},{"name":"Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"},{"name":"Department of Healthcare Quality and Research, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Schackman","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"},{"name":"Department of Healthcare Quality and Research, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula A.","family":"Chrysanthopoulou","sequence":"additional","affiliation":[{"name":"School of Public Health, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F.","family":"White","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Barocas","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"},{"name":"Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"issue":"356","key":"zoi201112r1","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2018.","author":"Hedegaard","year":"2020","journal-title":"NCHS Data Brief"},{"key":"zoi201112r3","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"zoi201112r4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi201112r5","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/add.v115.8","article-title":"Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.","volume":"115","author":"Walley","year":"2020","journal-title":"Addiction"},{"issue":"2","key":"zoi201112r6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi201112r7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.","volume":"85","author":"Morgan","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"7","key":"zoi201112r8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.v111.7","article-title":"Are take-home naloxone programmes effective: systematic review utilizing application of the Bradford Hill criteria.","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"key":"zoi201112r9","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"zoi201112r10","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S2468-2667(18)30044-6","article-title":"Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.","volume":"3","author":"Irvine","year":"2018","journal-title":"Lancet Public Health"},{"issue":"3","key":"zoi201112r11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/add.13668","article-title":"Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.","volume":"112","author":"Parmar","year":"2017","journal-title":"Addiction"},{"issue":"5","key":"zoi201112r12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/add.v111.5","article-title":"Effectiveness of Scotland\u2019s National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison.","volume":"111","author":"Bird","year":"2016","journal-title":"Addiction"},{"issue":"12","key":"zoi201112r13","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/add.2007.102.issue-12","article-title":"Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.","volume":"102","author":"Davoli","year":"2007","journal-title":"Addiction"},{"issue":"5","key":"zoi201112r17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.","volume":"11","author":"Soyka","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"zoi201112r19","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2105\/AJPH.2018.304673","article-title":"Estimated prevalence of opioid use disorder in Massachusetts, 2011-2015: a capture-recapture analysis.","volume":"108","author":"Barocas","year":"2018","journal-title":"Am J Public Health"},{"issue":"4","key":"zoi201112r20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/01.qai.0000186391.49205.3b","article-title":"Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.","volume":"41","author":"Neaigus","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"zoi201112r21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2014.03.029","article-title":"Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users.","volume":"140","author":"Nosyk","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi201112r22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.drugalcdep.2005.11.007","article-title":"Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.","volume":"83","author":"Shah","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"10118","key":"zoi201112r23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"1-2","key":"zoi201112r24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drugalcdep.2012.08.002","article-title":"Buprenorphine\/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial.","volume":"128","author":"Saxon","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"zoi201112r25","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.v114.9","article-title":"Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.","volume":"114","author":"Irvine","year":"2019","journal-title":"Addiction"},{"issue":"4","key":"zoi201112r27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0740-5472(03)00188-0","article-title":"Distance traveled to outpatient drug treatment and client retention.","volume":"25","author":"Beardsley","year":"2003","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"zoi201112r28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6373","article-title":"Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder.","volume":"2","author":"Haffajee","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi201112r29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1370\/afm.2384","article-title":"Comparing buprenorphine-prescribing physicians across nonmetropolitan and metropolitan areas in the United States.","volume":"17","author":"Lin","year":"2019","journal-title":"Ann Fam Med"},{"issue":"2","key":"zoi201112r30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/1475-6773.13113","article-title":"County-level access to opioid use disorder medications in Medicare Part D (2010-2015).","volume":"54","author":"Abraham","year":"2019","journal-title":"Health Serv Res"},{"issue":"1","key":"zoi201112r31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.","volume":"33","author":"Friedmann","year":"2012","journal-title":"Subst Abus"},{"issue":"8","key":"zoi201112r32","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/add.v115.8","article-title":"Commentary on Piske et al. (2020): Medication initiation is key to reduce deaths amid opioid crisis.","volume":"115","author":"Williams","year":"2020","journal-title":"Addiction"},{"issue":"11","key":"zoi201112r33","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/add.2006.101.issue-11","article-title":"Contingency management for treatment of substance use disorders: a meta-analysis.","volume":"101","author":"Prendergast","year":"2006","journal-title":"Addiction"},{"issue":"1","key":"zoi201112r34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13722-017-0072-2","article-title":"Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.","volume":"12","author":"Bhatraju","year":"2017","journal-title":"Addict Sci Clin Pract"},{"issue":"5","key":"zoi201112r35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2105\/AJPH.2018.304338","article-title":"Impact of Medicaid expansion on access to opioid analgesic medications and medication-assisted treatment.","volume":"108","author":"Sharp","year":"2018","journal-title":"Am J Public Health"},{"key":"zoi201112r36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cct.2018.11.015","article-title":"Remission from chronic opioid use\u2014studying environmental and socio-economic factors on recovery (RECOVER): study design and participant characteristics.","volume":"76","author":"Ling","year":"2019","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"zoi201112r37","first-page":"128","article-title":"Psychiatry and the opioid overdose crisis.","volume":"17","author":"Madras","year":"2019","journal-title":"Focus (Am Psychiatr Publ)"},{"issue":"4","key":"zoi201112r39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States.","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi201112r2","year":"2017"},{"key":"zoi201112r16","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health 2016","author":"Center for Behavioral Health Statistics and Quality","year":"2016"},{"key":"zoi201112r38","volume-title":"Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System","author":"Madras","year":"2020"},{"key":"zoi201112r14","unstructured":"National Institutes of Health. HEALing Communities Study. Accessed June 12, 2020. https:\/\/heal.nih.gov\/research\/research-to-practice\/healing-communities"},{"key":"zoi201112r15","unstructured":"Massachusetts Department of Public Health. An assessment of fatal and nonfatal opioid overdoses in Massachusetts (2011\u20132015). Accessed January 7, 2021. https:\/\/www.mass.gov\/doc\/legislative-report-chapter-55-opioid-overdose-study-august-2017\/download"},{"key":"zoi201112r18","unstructured":"Massachusetts Public Health Data Warehouse (PHD). 2020. Accessed June 12, 2020. https:\/\/www.mass.gov\/public-health-data-warehouse-phd"},{"key":"zoi201112r26","unstructured":"US Census Bureau. Urban and rural table. Accessed June 12, 2020. https:\/\/data.census.gov\/cedsci\/table?hidePreview=true&tid=DECENNIALSF12010.H2&vintage=2010"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2776442\/linas_2021_oi_201112_1612559253.38613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T21:32:58Z","timestamp":1613424778000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2776442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.37259","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}